{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:41Z","timestamp":1794324581301,"version":"4.9.0"},"reference-count":112,"publisher":"European Respiratory Society (ERS)","issue":"160","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,12,27]]},"published-print":{"date-parts":[[2021,6,30]]},"abstract":"<jats:p>Lysosomes are intracellular organelles that are responsible for degrading and recycling macromolecules. Lysosomal storage diseases (LSDs) are a group of inherited diseases caused by mutations affecting genes that encode the function of the lysosomal enzymes. Three LSDs are associated with lung involvement and\/or interstitial lung disease (ILD): Gaucher disease (GD); Niemann\u2013Pick disease, also known as acid sphingomyelinase deficiency (ASMD); and Fabry disease (FD). In GD and in ASMD, analysis of bronchoalveolar lavage fluid and lung biopsy can be informative, showing foamy cells. In GD, ILD is rare. Enzyme replacement therapy (ERT) has been available since 1991 and has greatly changed the natural history of GD, with pulmonary failure and death reported before the ERT era. In ASMD, ILD is frequent and is usually associated with spleen enlargement, low platelet cell count and low level of high-density lipoprotein-cholesterol. Results of ERT are promising regarding preliminary results of olipudase alfa in paediatric and adult ASMD populations. The most frequent respiratory manifestation in FD is COPD-like symptoms regardless of smoking habit and dyspnoea due to congestive heart failure. Early diagnosis of these three LSDs is crucial to prevent irreversible organ damage. Early initiation of ERT can, at least in part, prevent organ failure.<\/jats:p>","DOI":"10.1183\/16000617.0363-2020","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:00:21Z","timestamp":1619672421000},"page":"200363","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Interstitial lung disease in lysosomal storage disorders"],"prefix":"10.1183","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9906-0024","authenticated-orcid":false,"given":"Rapha\u00ebl","family":"Borie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Guyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lidove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"2024102403541008000_30.160.200363.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2004.03.003"},{"key":"2024102403541008000_30.160.200363.2","doi-asserted-by":"publisher","DOI":"10.1111\/tra.12646"},{"key":"2024102403541008000_30.160.200363.3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/ijms20020327","article-title":"Molecular pathways and respiratory involvement in lysosomal storage diseases","volume":"20","author":"Faverio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024102403541008000_30.160.200363.4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-019-1037-1","article-title":"Is early detection of late-onset Pompe disease a pneumologist's affair? A lesson from an Italian screening study","volume":"14","author":"Confalonieri","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl. 4","key":"2024102403541008000_30.160.200363.5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imj.15100","article-title":"Treatable lysosomal storage diseases in the advent of disease-specific therapy","volume":"50","author":"Peters","year":"2020","journal-title":"Intern Med J"},{"key":"2024102403541008000_30.160.200363.6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","article-title":"Gaucher disease epidemiology and natural history: a comprehensive review of the literature","volume":"22","author":"Nalysnyk","year":"2017","journal-title":"Hematology"},{"key":"2024102403541008000_30.160.200363.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"2024102403541008000_30.160.200363.8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1750-1172-7-77","article-title":"The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients","volume":"7","author":"Stirnemann","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"2024102403541008000_30.160.200363.9","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.160.6.603"},{"key":"2024102403541008000_30.160.200363.10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<140::AID-AJH14>3.0.CO;2-T","article-title":"Life-threatening splenic hemorrhage in two patients with Gaucher disease","volume":"64","author":"Stone","year":"2000","journal-title":"Am J Hematol"},{"key":"2024102403541008000_30.160.200363.11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2010.03168.x","article-title":"Long-term outcomes of liver transplantation in type 1 Gaucher disease","volume":"10","author":"Ayto","year":"2010","journal-title":"Am J Transplant"},{"key":"2024102403541008000_30.160.200363.12","first-page":"151","article-title":"Survey of hematological aspects of Gaucher disease","volume":"10","author":"Zimran","year":"2005","journal-title":"Hematol Amst Neth"},{"key":"2024102403541008000_30.160.200363.13","doi-asserted-by":"publisher","DOI":"10.1080\/08880010600623232"},{"key":"2024102403541008000_30.160.200363.14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.75.suppl_1.750002"},{"key":"2024102403541008000_30.160.200363.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0059-x"},{"key":"2024102403541008000_30.160.200363.16","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000005623.60471.51"},{"key":"2024102403541008000_30.160.200363.17","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq198"},{"key":"2024102403541008000_30.160.200363.18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13023-020-01529-y","article-title":"Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?","volume":"15","author":"Di Rocco","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2024102403541008000_30.160.200363.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508808"},{"key":"2024102403541008000_30.160.200363.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.02.007"},{"key":"2024102403541008000_30.160.200363.21","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.8.407"},{"key":"2024102403541008000_30.160.200363.22","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0004.2003.00060.x"},{"key":"2024102403541008000_30.160.200363.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09020340"},{"key":"2024102403541008000_30.160.200363.24","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9706057"},{"key":"2024102403541008000_30.160.200363.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.06.014"},{"key":"2024102403541008000_30.160.200363.26","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.chest.2015.09.011","article-title":"Lung transplantation in Gaucher disease: a learning lesson in trying to avoid both scylla and charybdis","volume":"149","author":"de Boer","year":"2016","journal-title":"Chest"},{"key":"2024102403541008000_30.160.200363.27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2559.2012.04261.x","article-title":"Pulmonary arterial hypertension with plexogenic arteriopathy in enzyme-substituted Gaucher disease","volume":"61","author":"den Bakker","year":"2012","journal-title":"Histopathology"},{"key":"2024102403541008000_30.160.200363.28","first-page":"100893","article-title":"Lessons from lung transplantation: cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease","volume":"28","author":"Goobie","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"2024102403541008000_30.160.200363.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1096-7192(02)00122-1"},{"key":"2024102403541008000_30.160.200363.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.038083"},{"key":"2024102403541008000_30.160.200363.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9313-9"},{"key":"2024102403541008000_30.160.200363.32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"Suppl. 1","key":"2024102403541008000_30.160.200363.33","first-page":"S12","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher Registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am J Hematol"},{"key":"2024102403541008000_30.160.200363.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91037-9"},{"key":"2024102403541008000_30.160.200363.35","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90288-1"},{"key":"2024102403541008000_30.160.200363.36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ajh.23382","article-title":"Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease","volume":"88","author":"Ben Turkia","year":"2013","journal-title":"Am J Hematol"},{"key":"2024102403541008000_30.160.200363.37","doi-asserted-by":"crossref","first-page":"100490","DOI":"10.1016\/j.ymgmr.2019.100490","article-title":"Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy","volume":"20","author":"Beshlawy","year":"2019","journal-title":"Mol Genet Metab Rep"},{"key":"2024102403541008000_30.160.200363.38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bcmd.2016.11.006","article-title":"Histological characterisation of visceral changes in a patient with type 2 Gaucher disease treated with enzyme replacement therapy","volume":"68","author":"Tezuka","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"2024102403541008000_30.160.200363.39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1399-3046.2005.00251.x","article-title":"Bilateral lung transplant in Gauchers type-1 disease","volume":"9","author":"Rao","year":"2005","journal-title":"Pediatr Transplant"},{"key":"2024102403541008000_30.160.200363.40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/ajh.25875","article-title":"Real-world effectiveness of eliglustat in treatment-na\u00efve and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry","volume":"95","author":"Mistry","year":"2020","journal-title":"Am J Hematol"},{"key":"2024102403541008000_30.160.200363.41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009734.2013.857373","article-title":"Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease","volume":"119","author":"Machaczka","year":"2014","journal-title":"Ups J Med Sci"},{"key":"2024102403541008000_30.160.200363.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10194-0"},{"key":"2024102403541008000_30.160.200363.43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00408-016-9893-0","article-title":"Pulmonary involvement in Niemann\u2013Pick disease: a state-of-the-art review","volume":"194","author":"von Ranke","year":"2016","journal-title":"Lung"},{"key":"2024102403541008000_30.160.200363.44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ejhg.2015.89","article-title":"Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann\u2013Pick disease type B","volume":"24","author":"Acu\u00f1a","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"2024102403541008000_30.160.200363.45","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0632-9"},{"key":"2024102403541008000_30.160.200363.46","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3016"},{"key":"2024102403541008000_30.160.200363.47","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31825793ff"},{"key":"2024102403541008000_30.160.200363.48","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2013.4"},{"key":"2024102403541008000_30.160.200363.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.06.034"},{"key":"2024102403541008000_30.160.200363.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.10.034"},{"key":"2024102403541008000_30.160.200363.51","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.113"},{"key":"2024102403541008000_30.160.200363.52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10545-012-9503-0","article-title":"Skeletal manifestations in pediatric and adult patients with Niemann\u2013Pick disease type B","volume":"36","author":"Wasserstein","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"2024102403541008000_30.160.200363.53","first-page":"43","article-title":"Niemann\u2013Pick disease; report of a case showing calcification in the adrenal glands","volume":"45","author":"Alexander","year":"1946","journal-title":"N Z Med J"},{"key":"2024102403541008000_30.160.200363.54","unstructured":"Wasserstein MP , Schuchman EH . Acid sphingomyelinase deficiency. In: Adam MP , Ardinger HH , Pagon RA , et al. , eds. GeneReviews. Seattle, University of Washington, 1993. www.ncbi.nlm.nih.gov\/books\/NBK1370\/"},{"key":"2024102403541008000_30.160.200363.55","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20725"},{"key":"2024102403541008000_30.160.200363.56","first-page":"13","article-title":"Respiratory impairment in Niemann\u2013Pick B disease: two case reports and review for the pulmonologist","volume":"76","author":"Capron","year":"2019","journal-title":"Respir Med Res"},{"key":"2024102403541008000_30.160.200363.57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymgme.2012.06.015","article-title":"Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients","volume":"107","author":"Hollak","year":"2012","journal-title":"Mol Genet Metab"},{"key":"2024102403541008000_30.160.200363.58","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2381041696"},{"key":"2024102403541008000_30.160.200363.59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1590\/s1806-37562017000000062","article-title":"Niemann\u2013Pick disease type B: HRCT assessment of pulmonary involvement","volume":"43","author":"Freitas","year":"2017","journal-title":"J Bras Pneumol"},{"key":"2024102403541008000_30.160.200363.60","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2000.0942"},{"key":"2024102403541008000_30.160.200363.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2004.07.003"},{"key":"2024102403541008000_30.160.200363.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02355.x"},{"key":"2024102403541008000_30.160.200363.63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann\u2013Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"2024102403541008000_30.160.200363.64","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0105-y"},{"key":"2024102403541008000_30.160.200363.65","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0887"},{"key":"2024102403541008000_30.160.200363.66","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-5671-5"},{"key":"2024102403541008000_30.160.200363.67","doi-asserted-by":"publisher","DOI":"10.1086\/345074"},{"key":"2024102403541008000_30.160.200363.68","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.revmed.2014.10.367","article-title":"D\u00e9ficit en sphingomy\u00e9linase acide et rupture spl\u00e9nique: spl\u00e9nectomie ou traitement conservateur? [Acid sphingomyelinase deficiency and spleen trauma: splenectomy or not splenectomy?]","volume":"36","author":"Lidove","year":"2015","journal-title":"Rev Med Interne"},{"key":"2024102403541008000_30.160.200363.69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2009.01325.x"},{"key":"2024102403541008000_30.160.200363.70","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20248"},{"key":"2024102403541008000_30.160.200363.71","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.1.2103113"},{"key":"2024102403541008000_30.160.200363.72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.healun.2018.10.002","article-title":"Lung transplantation in a patient with Niemann\u2013Pick disease","volume":"38","author":"Mannem","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403541008000_30.160.200363.73","first-page":"9431751","article-title":"Pulmonary type B Niemann\u2013Pick disease successfully treated with lung transplantation","volume":"2019","author":"O'Neill","year":"2019","journal-title":"Case Rep Transplant"},{"key":"2024102403541008000_30.160.200363.74","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.healun.2019.01.002","article-title":"Successful lung transplantation in a patient with Niemann\u2013Pick disease","volume":"38","author":"Ding","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403541008000_30.160.200363.75","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.healun.2019.02.008","article-title":"Acid sphingomyelinase deficiency (Niemann\u2013Pick disease Type B) as an inflammatory disease","volume":"38","author":"Lidove","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2024102403541008000_30.160.200363.76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/gim.2015.24","article-title":"Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann\u2013Pick disease type B (acid sphingomyelinase deficiency)","volume":"18","author":"McGovern","year":"2016","journal-title":"Genet Med"},{"key":"2024102403541008000_30.160.200363.77","unstructured":"Sanofi . Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency . Press Release, January 30, 2020. www.sanofi.com\/media-room\/press-releases\/2020\/2020-01-30_07-00-00_1977201 Date last accessed: February 11, 2021. Date last updated: January 30, 2020."},{"key":"2024102403541008000_30.160.200363.78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61589-5"},{"key":"2024102403541008000_30.160.200363.79","doi-asserted-by":"crossref","first-page":"e0233460","DOI":"10.1371\/journal.pone.0233460","article-title":"Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease","volume":"15","author":"Mauhin","year":"2020","journal-title":"PLoS One"},{"key":"2024102403541008000_30.160.200363.80","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.5.498"},{"key":"2024102403541008000_30.160.200363.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.08.012"},{"key":"2024102403541008000_30.160.200363.82","doi-asserted-by":"publisher","DOI":"10.1097\/01.gim.0000237866.70357.c6"},{"key":"2024102403541008000_30.160.200363.83","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08002.x"},{"key":"2024102403541008000_30.160.200363.84","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30"},{"key":"2024102403541008000_30.160.200363.85","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.100602"},{"key":"2024102403541008000_30.160.200363.86","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08091109"},{"key":"2024102403541008000_30.160.200363.87","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2008.065904"},{"key":"2024102403541008000_30.160.200363.88","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.105105"},{"key":"2024102403541008000_30.160.200363.89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2005.03.004"},{"key":"2024102403541008000_30.160.200363.90","doi-asserted-by":"crossref","first-page":"e4996","DOI":"10.1097\/MD.0000000000004996","article-title":"Cardiac device implantation in Fabry disease: a retrospective monocentric study","volume":"95","author":"Sen\u00e9","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2024102403541008000_30.160.200363.91","doi-asserted-by":"crossref","first-page":"f153","DOI":"10.1093\/europace\/eux261","article-title":"Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice","volume":"20","author":"Baig","year":"2018","journal-title":"Europace"},{"key":"2024102403541008000_30.160.200363.92","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70548-8"},{"key":"2024102403541008000_30.160.200363.93","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.526293"},{"key":"2024102403541008000_30.160.200363.94","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00415-007-0575-y","article-title":"Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy","volume":"254","author":"Palla","year":"2007","journal-title":"J Neurol"},{"key":"2024102403541008000_30.160.200363.95","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000277"},{"key":"2024102403541008000_30.160.200363.96","unstructured":"Aubert JD , Barbey F . Pulmonary involvement in Fabry disease. In: Mehta A , Beck M , Sunder-Plassmann G , eds. Fabry Disease: Perspectives from 5 Years of FOS. Oxford, Oxford PharmaGenesis, 2006. www.ncbi.nlm.nih.gov\/books\/NBK11589\/"},{"key":"2024102403541008000_30.160.200363.97","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00004110"},{"key":"2024102403541008000_30.160.200363.98","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-007-0616-9"},{"key":"2024102403541008000_30.160.200363.99","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ejim.2013.05.003","article-title":"Pulmonary involvement in Fabry disease: overview and perspectives","volume":"24","author":"Franzen","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2024102403541008000_30.160.200363.100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3402\/ecrj.v2.26721","article-title":"Fabry disease, respiratory symptoms, and airway limitation \u2013 a systematic review","volume":"2","author":"Svensson","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"2024102403541008000_30.160.200363.101","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2143\/AC.65.2.2047052","article-title":"Cardiopulmonary involvement in Fabry's disease","volume":"65","author":"Koskenvuo","year":"2010","journal-title":"Acta Cardiol"},{"issue":"Suppl. 2","key":"2024102403541008000_30.160.200363.102","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1007\/s10545-008-0930-x","article-title":"Enzyme replacement therapy stabilizes obstructive pulmonary Fabry disease associated with respiratory globotriaosylceramide storage","volume":"31","author":"Wang","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"2024102403541008000_30.160.200363.103","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ajmg.a.31600","article-title":"Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy","volume":"143","author":"Kim","year":"2007","journal-title":"Am J Med Genet A"},{"key":"2024102403541008000_30.160.200363.104","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0800"},{"key":"2024102403541008000_30.160.200363.105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.10.019"},{"key":"2024102403541008000_30.160.200363.106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10545-017-0127-2","article-title":"Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease","volume":"41","author":"Alharbi","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"2024102403541008000_30.160.200363.107","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2013-101857"},{"key":"2024102403541008000_30.160.200363.108","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13023-019-1256-5","article-title":"Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis","volume":"14","author":"Borie","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"2024102403541008000_30.160.200363.109","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008080870"},{"key":"2024102403541008000_30.160.200363.110","doi-asserted-by":"publisher","DOI":"10.1023\/B:BOLI.0000005658.14563.77"},{"key":"2024102403541008000_30.160.200363.111","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104178"},{"key":"2024102403541008000_30.160.200363.112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J Rare Dis"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0363-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:03:09Z","timestamp":1740355389000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0363-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":112,"journal-issue":{"issue":"160","published-online":{"date-parts":[[2021,4,29]]},"published-print":{"date-parts":[[2021,6,30]]}},"alternative-id":["10.1183\/16000617.0363-2020"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0363-2020","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]}}}